Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsThe pharmaceutical company saw revenue rise 6.6 percent yoy to Rp 12.37 trillion in the January-June period, supported by higher sales in its distribution services, prescription drug and consumer health product segments. The nutritional segment booked a decline.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.